According to the latest report by IMARC Group “3D Cell Culture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global 3D cell culture market size reached US$ 1,746 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 4,123 Million by 2027, exhibiting a CAGR of 15.28% during 2022-2027.
A three-dimensional (3D) cell culture refers to an in vitro technique used for growing biological cells in an artificially created environment. It offers an advanced and vigorous platform for analyzing complex biological processes and mimicking the activity, structure, and microenvironment of the in-vivo tissues. As a result, it finds applications in stem cell therapies, drug screening, regenerative medicine, neuroscience, cancer research, and cell biology.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a free sample copy of this report: https://www.imarcgroup.com/3d-cell-culture-market/requestsample
The rising geriatric population, which is more vulnerable to chronic medical disorders, represents one of the key factors driving the market. In addition, the increasing demand for personalized medicines among patients is positively influencing the market. Furthermore, the growing need for effective alternatives to animal testing, along with the development of microfluidics-based 3D cell cultures with enhanced cell viability, proliferation, and differentiation, is offering lucrative growth opportunities to industry investors. Moreover, extensive research and development (R&D) activities in the field of biotechnology are anticipated to propel market growth.
Breakup by Product:
- Scaffold-Based Platforms
- Scaffold-Free Platforms
Breakup by Application:
- Cancer Research
- Stem Cell Research
- Drug Discovery
- Regenerative Medicine
Breakup by End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Laboratories
- Academic Institutes
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- 3D Biotek LLC
- Advanced Biomatrix Inc.
- Avantor Inc.
- CN Bio Innovations Limited
- Corning Incorporated
- Emulate Inc.
- InSphero AG
- Lonza Group AG
- Merck KGaA
- Promocell GmbH
- Synthecon Inc
- Thermo Fisher Scientific Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/3d-cell-culture-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800